Clinical Trial Update: International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia [Phase 3]

View source ↗

Summary

An international, multicenter phase 3 study evaluating one-year, open-label, titrated oral tolvaptan in patients with chronic hyponatremia; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• Samsca (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Hyponatremia | Phase 3 | Status: COMPLETED | Results posted: 2016-01-21